Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Clovis Oncology 

1871 Folsom Street

Boulder  Colorado  80302  U.S.A.
Phone: n/a Fax: n/a


 Company News
Clovis Oncology (CLVS) Announces First Patient Enrolled In Lucitanib Phase 2 Study In Squamous Non-small Cell Lung Cancer 10/24/2014 11:19:43 AM
Clovis Oncology (CLVS) To Announce Third Quarter 2014 Financial Results And Host Webcast Conference Call On November 6 10/22/2014 9:54:18 AM
Tiny Clovis Oncology (CLVS) Races With AstraZeneca PLC (AZN) To Develop Lung Cancer Drug 10/2/2014 6:11:31 AM
Clovis Oncology (CLVS) Release: Data From Ongoing Phase 2 Studies Of Rucaparib In Ovarian Cancer Demonstrate Safety And Clinical Activity, Validate Differentiated Strategy 9/29/2014 2:11:24 PM
Clovis Oncology (CLVS) Announces First Patient Enrolled in Lucitanib Phase 2 Study In FGF-aberrant Advanced Breast Cancer 9/11/2014 11:17:08 AM
Clovis Oncology (CLVS) Announces Exercise In Full By Initial Purchasers Of Their Option To Purchase An Additional $37.5 Million Aggregate Principal Amount Of The Company’s 2.50% Convertible Senior Notes Due 2021 9/9/2014 10:36:55 AM
Clovis Oncology (CLVS) To Present At The 2014 Morgan Stanley Global Healthcare Conference 9/8/2014 10:00:20 AM
Clovis Oncology (CLVS) Announces Pricing Of $250 Million Of Convertible Senior Notes 9/4/2014 12:36:52 PM
Clovis Oncology (CLVS) To Offer $200 Million Of Convertible Senior Notes 9/3/2014 1:49:54 PM
Clovis Oncology (CLVS) Announces Second Quarter 2014 Operating Results 8/8/2014 9:06:05 AM